Qeen Biotechnologies

Focus: Qeen Biotechnologies is a bacteriophage-focused biotech company headquartered in Gatineau, Quebec, developing novel phage-based therapeutics.

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Qeen Biotechnologies

AI assessmentNot Hiring

No open roles listed right now. Follow Qeen Biotechnologies to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Five phage anti-Staphylococcus aureus bacteriophage cocktail

Prosthetic Joint Infections of Hip

Phase 1/2

Clinical Trials (1)

NCT07461337Bacteriophage Therapy for Staphylococcus Lugdunensis Prosthetic Joint Infection

Phase 1/2

Help build intelligence for Qeen Biotechnologies

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pioneering bacteriophage modality with potential to address antimicrobial resistance—a high-impact, emerging therapeutic space
Early-stage company offers opportunity to shape scientific direction and build core capabilities from the ground up
Location in Quebec provides access to strong academic and biotech ecosystem support

Watch Out For

No disclosed funding, revenue, or active clinical trials limits visibility on financial runway and development momentum
Minimal public hiring signal (zero active job postings) and absence of employee count suggests very early stage or dormant operations
Lack of published clinical data, patent disclosures, or recent news raises questions about scientific validation and execution

Generated by Claude from Qeen Biotechnologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

phage therapy

Prosthetic Joint Infections of Hip

Phase 1/2

Clinical Trials (1)

NCT06814756Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection

Phase 1/2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo